Stability of proteins and nucleic acids

Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids

Volumn , Issue , 2004, Pages 351-375

  Lu, Zheng Rong ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903794671     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (37)

1. Voet, D., Voet, J. G., Biochemistry, 2nd Ed. John Wiley & Sons, Inc., New York, 1995.
2. Manning, M. C., Patel, K., Borchardt, R. T., Stability of protein pharmaceuticals. Pham. Res. 1989; 6: 903-918.
3. Wang, W., Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pham., 1999; 185: 129-188.
4. Zale, S. E., and Klibanov, A. M., Why does ribonuclease irreversibly inactivate at high temperatures? Biochemistry, 1986; 25: 5432-5444.
5. Xie, M., and Schowen, R. L., Secondary structure and protein deamidation. J. Pharm. Sci., 1999; 88: 8-13.
6. Xie, M. et al., Asparagine deamidation in recombinant human lymphotoxin: hindrance by three-dimensional structures. J. Pharm. Sci., 2003; 92: 869-880.
7. Nguyen, T. H., Burnier, J., Meng, W., The kinetics of relaxin oxidation by hydrogen peroxide. Pharm. Res., 1993; 10: 1563-1571.
8. Khossravi, M., and Borchardt, R. T., Chemical pathways of peptide degradation: IX. Metal-catalyzed oxidation of histidine in model peptides. Pharm. Res., 1998; 15: 1096-1102.
9. Li, S., Nguyen, T. H., Schoneich, C., Borchardt, R. T., Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry, 1995; 34: 5762-5772.
10. Shen, H. R., Spikes, J. D., Kopeckova, P., Kopecek, J., Photodynamic crosslinking of proteins. II. Photocrosslinking of a model protein-ribonuclease A. J. Photochem. Photobiol. B, 1996; 35: 213-219.
11. Browning, J. L. et al., Disulfide scrambling of interleukin-2: HPLC resolution of the three possible isomers. Anal. Biochem., 1986; 155: 123-128.
12. Brange, J. et al., Toward understanding insulin fibrillation. J. Pharm. Sci., 1997; 86: 517-525.
13. Tandon, S., and Horowitz, P. M., Detergent-assisted refolding of guanidinium chloride-denatured rhodanese. The effects of the concentration and type of detergent. J. Biol. Chem., 1987; 262: 4486-4491.
14. Gekko, K, and Timasheff, S. N., Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. Biochemistry, 1981; 20: 4667-4676.
15. Betz, S. F. et al., Unusual effects of an engineered disulfide on global and local protein stability. Biochemistry, 1996; 35: 7422-7428.
16. Lu, Z. R., Kopeckova, P., Wu, Z., and Kopecek, J., Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification. Bioconjug. Chem., 1998; 9: 793-804.
17. Strop, P., and Mayo, S. L., Contribution of surface salt bridges to protein stability. Biochemistry, 2000; 39: 1251-1255.
18. Pantoliano, M. W. et al., The engineering of binding affinity at metal ion binding sites for the stabilization of proteins: subtilisin as a test case. Biochemistry, 1988; 27: 8311-8317.
19. Burrows, C. J., and Muller, J. G., Oxidative nucleobase modifications leading to strand scission. Chem. Rev., 1998; 98: 1109-1152.
20. Oivanen, M., Kuusela, S., and Lonnberg, H., Kinetics and mechanisms for the cleavage and isomerization of the phosphodiester bonds of RNA by Bronsted acids and bases. Chem. Rev., 1998; 98: 961-990.
21. Pogozelski, W. K., and Tullius, T. D., Oxidative strand scission of nucleic acids: routes initiated by hydrogen abstraction from the sugar moiety. Chem. Rev., 1998; 98: 1089-1108.
22. Armitage, B., Photocleavage of nucleic acids. Chem. Rev., 1998; 98: 1171-1200.
23. Pogocki, D., and Schoneich, C., Chemical stability of nucleic acid-derived drugs. J. Pharm. Sci., 2000; 89: 443-456.
24. 0-dinucleosidic monophosphates: kinetics and mechanisms. J. Org. Chem., 1991; 56: 5396-5401.
25. 0-hydroxyl group. J. Am. Chem. Soc., 1999; 121: 5364-5372.
26. Anslyn EaB, R., On the mechanism of catalysis by ribonuclease: cleavage and isomerization of the dinucleotide UpU catalyzed by midazole buffers. J. Am. Chem. Soc, 1989; 111: 4473-4482.
27. Breslow, R., Dong, S. D., Webb, Y., and Xu, R., Further studies on the buffer-catalyzed cleavage and isomerization of uridyluridine. Medium and ionic strength effects on catalysis by morpholin, imidazole and acetate buffers help clarify the mechanisms involved and their relationship to the mechanism used by the enzyme ribonuclease and by a ribonuclease mimic. J. Am. Chem. Soc., 1996; 118: 6588-6600.
28. Lindahl, T., Instability and decay of the primary structure of DNA. Nature, 1993; 362: 709-715.
29. Garrett, E. R., and Mehta, P. J., Solvolysis of adenine nucleosides. II. Effects of sugars and adenine substituents on alkaline solvolyses. J. Am. Chem. Soc., 1972; 94: 8542-8547.
30. Lindahl, T., and Andersson, A., Rate of chain breakage at apurinic sites in double-stranded deoxyribonucleic acid. Biochemistry, 1972; 11: 3618-3623.
31. Lindahl, T., and Nyberg, B., Rate of depurination of native deoxyribonucleic acid. Biochemistry, 1972; 11: 3610-3618.
32. Lindahl, T., and Karlstrom, O., Heat-induced depyrimidination of deoxyribonucleic acid in neutral solution. Biochemistry, 1973; 12: 5151-5154.
33. Lindahl, T., and Nyberg, B., Heat-induced deamination of cytosine residues in deoxyribonucleic acid. Biochemistry, 1974; 13: 3405-3410.
34. Evans, R. K. et al., Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. J. Pharm. Sci., 2000; 89: 76-87.
35. Middaugh, C. R., Evans, R. K., Montgomery, D. L., and Casimiro, D. R., Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci., 1998; 87: 130-146.
36. Adami, R. C. et al., Stability of peptide-condensed plasmid DNA formulations. J. Pharm. Sci., 1998; 87: 678-683.
37. Anchordoquy, T. J., and Koe, G. S., Physical stability of nonviral plasmid-based therapeutics. J. Pharm. Sci., 2000; 89: 289-296.